In a written statement, Bayer said "that it mistakenly did not inform" the F. D. A. of the study and added, "This data was not Shared immediately with the agency because it was preliminary in nature."

以书面的形式，拜耳公司公司称其“错误地没有及时告知”FDA这一研究，并且还追加一句，“这些资料是因为还仅仅是原始资料未及分析所以才没有立即告知当局的”。